HAHüseyin Aykaç

Hüseyin Aykaç

*This is an algorithmically generated author record based on publicly available information.

Hüseyin Aykaç has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Relationship Between Growth Differentiation Factor-15 Levels and Micro-Atrial Fibrillation

    by Hüseyin Orta, Cihan Aydın, Aykut Demirkıran, Hüseyin Aykaç, Ahsen Yılmaz

    Objective: Micro-atrial fibrillation (micro-AF) represents short, irregular supraventricular tachyarrhythmia episodes that may precede clinical atrial fibrillation (AF). Identifying biomarkers associated with micro-AF could improve early detection and risk stratification. Growth Differentiation Factor-15 (GDF-15), a stress-responsive cytokine related to inflammation and myocardial injury, has been associated with AF, but its relationship with micro-AF remains unclear. Methods: Ninety patients who underwent 24-hour Holter monitoring due to palpitations were enrolled. Forty-five patients with micro-AF and 45 controls without supraventricular tachyarrhythmia were compared. Serum GDF-15 levels and clinical characteristics were analyzed using standard statistical methods, including logistic regression analysis and Receiver Operating Characteristic (ROC) curve analyses. Results: The groups were similar in age, sex, and comorbidities. Prior stroke was significantly more frequent in the micro-AF group (28.8% vs. 6.7%, P<0.001). Mean serum GDF-15 levels were significantly higher in patients with micro-AF than in controls (544.2±322.5 vs. 344±138.8 pg/mL, P<0.001). Logistic regression revealed that GDF-15 was associated with stroke risk in univariate analysis but not independently in multivariate analysis. Conclusion: Elevated GDF-15 levels in individuals with micro-AF suggest an underlying inflammatory or structural atrial substrate, supporting its potential role as a biomarker for early arrhythmia detection and assessment of thromboembolic risk. Larger, prospective studies are warranted to clarify the prognostic significance of GDF-15 in micro-AF.

  • Open Access

    Effect of transdermally applied nitroglycerin or lidocaine before transradial coronary angiography on procedure success and complications

    by Nurullah Uslu, Cihan Aydın, Aykut Demirkıran, Hüseyin Aykaç, Şeref Alpsoy

    Objective: We investigated the effect of transdermal nitroglycerin or lidocaine application on puncture time, number, and complications in patients who underwent transradial coronary angiography. Methods: Patients with topical saline applied to the radial artery before the procedure were designated as Group 1 (n=59), those with topical nitrate were designated as Group 2 (n=43), and those with topical lidocaine were designated as Group 3 (n=40). The groups' puncture time, number, and complication rates were compared. Results: While our average puncture time was 142±122 seconds in all patients, this time was measured as 171±131 seconds in Group 1, 88±48 seconds in Group 2, and 157±146 seconds in Group 3 (P=0.021). During the procedure, radial artery spasm was observed in 15.2% of patients in Group 1, 6.9% in Group 2, and 12.5% in Group 3 (P=0.043). Radial artery occlusion was seen in 8% of patients in Group 1, and 2.5% in Group 3, while it was not observed at all in the nitrate-applied group (P=0.041). Conclusion: The topical application of nitroglycerin before transradial angiography is a feasible strategy to reduce radial puncture time and number, facilitate trans-radial catheterization, and decrease the incidence of radial artery spasm and occlusion.

  • Open Access

    Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation

    by Hüseyin Aykaç, Cihan Aydın, Aykut Demirkıran, Nurullah Uslu, Şeref Alpsoy

    Aim . Atrial fibrillation (AF) is a rhythm disorder characterized by very rapid and disorganized atrial-derived electrical activations with uncoordinated atrial contractions. Very short periods of AF-like activity (micro-AF) may be precursors of undetected, silent episodes of atrial fibrillation. Here, we examined the relationship between natriuretic peptide concentrations and echocardiography findings in patients with micro-AF. Material and methods . The electrocardiograms (ECGs) of patients complaining of palpitations were recorded with a 24‑hour Holter monitor, and the patients were consecutively included in the study. Micro-AF was defined as sudden, irregular atrial tachycardia lasting less than 30 sec with episodes of ≥5 consecutive supraventricular depolarizations with the absolute absence of p-waves. After a G-power test, patients were consecutively included in the study: 45 patients in the micro-AF group and 45 patients in the control group. Laboratory parameters, ECG and echocardiographic findings of the two groups were compared. Results . N-terminal pro B-type natriuretic peptide (Pro-BNP) and serum troponin T concentrations were higher in the micro-AF group, (375.5±63.6 pg / ml vs. 63.1±56.8 pg / ml, pConclusions . Micro-AF in patients may be predicted by evaluating ECG, echocardiographic, and serum natriuretic peptide data.


  • Open Access

    Can the Glasgow prognostic score predict ischemic stroke in patients with infective endocarditis?

    by Cihan Aydın, Aykut Demirkıran, Hüseyin Aykaç, Nurullah Uslu, Şeref Alpsoy

    OBJECTIVE: The Glasgow prognosis score is a simple parameter calculated using serum levels of albumin and C-reactive protein. The aim of this study was to examine whether this parameter may predict ischemic stroke in patients with infective endocarditis.


  • Open Access

    Association of lower serum irisin levels with diabetes mellitus: Irrespective of coronary collateral circulation, and syntax score

    by Aydin Akyuz, Beysim Mert, Demet Ozkaramanli Gur, Muhammet Mucip Efe, Huseyin Aykac, Seref Alpsoy, Savas Guzel

    OBJECTIVE: Irisin is a myokine thought to be involved in the pathophysiological process of atherosclerosis with its' cardiovascular protective effects. Patients with diabetes mellitus (DM) have lower levels of irisin. Therefore, we investigated whether there is a connection between irisin, DM, coronary collateral circulation (CCC), and SYNTAX scores representing coronary artery disease (CAD) severity. METHODS: This study evaluated 86 patients who have at least one epicardial coronary artery with chronic total occlusion. We included Rentrop 0-1 into the poor CCC group (n=45) and Rentrop 2-3 into the good CCC group (n=41) and measured serum irisin levels. RESULTS: Irisin levels did not differ (17585 [882-37741] pg/ml and (17504 [813-47683] pg/ml, p=0.772) between the two groups. Irisin levels were lower in patients with diabetes (n=41; 14485 [813-29398] pg/ml) than those without diabetes (n=45; 19724 [865-47683] pg/ml (p=0.002). Irisin was not correlated with SYNTAX scores. In multivariate analysis, DM (OR=0.463; CI: 0.184-0.783; p=0.012) was a negative predictor of good CCC development CONCLUSION: Although its level is decreased in patients with diabetes, serum irisin levels have no role in the pathophysiology of collateral development and CAD severity.